Gene · 10112
Papers1,613
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,613
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Bulk- and single cell-RNA sequencing reveal KIF20A as a key driver of hepatocellular carcinoma progression and immune evasion. | Front Immunol | 2024 | 39555078 | PubTator, text mining | PubMed |
| Unveiling the genetic link and pathogenesis between psoriasis and IgA nephropathy based on Mendelian randomization and transcriptome data analyses. | Arch Dermatol Res | 2024 | 39460798 | PubTator, text mining | PubMed |
| Influence of Genetic Polymorphisms on the Age at Cancer Diagnosis in a Homogenous Lynch Syndrome Cohort of Individuals Carrying the MLH1:c.1528C>T South African Founder Variant. | Biomedicines | 2024 | 39457514 | PubTator, text mining | PubMed |
| A Bioinformatics-Based Approach to Discover Novel Biomarkers in Hepatocellular Carcinoma. | Iran J Public Health | 2024 | 39430152 | PubTator, text mining | PubMed |
| Exploration of the link between COVID-19 and gastric cancer from the perspective of bioinformatics and systems biology. | Front Med (Lausanne) | 2024 | 39371335 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing reveals the communications between tumor microenvironment components and tumor metastasis in osteosarcoma. | Front Immunol | 2024 | 39324133 | PubTator, text mining | PubMed |
| Artificial intelligence and bioinformatics: a journey from traditional techniques to smart approaches. | Gastroenterol Hepatol Bed Bench | 2024 | 39308539 | PubTator, text mining | PubMed |
| Advancing Cancer Therapy: The Role of KIF20A as a Target for Inhibitor Development and Immunotherapy. | Cancers (Basel) | 2024 | 39272816 | PubTator, text mining | PubMed |
| Fluspirilene exerts an anti-glioblastoma effect through suppression of the FOXM1-KIF20A axis. | Neoplasma | 2024 | 39267533 | PubTator, text mining | PubMed |
| Transcriptomic landscape of quiescent and proliferating human corneal stromal fibroblasts. | Exp Eye Res | 2024 | 39243928 | PubTator, text mining | PubMed |
| Esophageal chemical burns as a risk factor for esophageal malignancies: in-silico analyses - experimental research. | Ann Med Surg (Lond) | 2024 | 39239040 | PubTator, text mining | PubMed |
| Identification of Hub Genes for Psoriasis and Cancer by Bioinformatic Analysis. | Biomed Res Int | 2024 | 39045407 | PubTator, text mining | PubMed |
| Identification of novel biomarkers and potential molecular targets for uterine cancer using network-based approach. | Pathol Res Pract | 2024 | 39029376 | PubTator, text mining | PubMed |
| Inhibition of KIF20A enhances the immunotherapeutic effect of hepatocellular carcinoma by enhancing c-Myc ubiquitination. | Cancer Lett | 2024 | 38971490 | PubTator, text mining | PubMed |
| Novel Therapies for ANCA-associated Vasculitis: Apilimod Ameliorated Endothelial Cells Injury through TLR4/NF-κB Pathway and NLRP3 Inflammasome. | Curr Pharm Des | 2024 | 38910483 | PubTator, text mining | PubMed |
| The Aurora B-controlled PP1/RepoMan complex determines the spatial and temporal distribution of mitotic H2B S6 phosphorylation. | Open Biol | 2024 | 38806145 | PubTator, text mining | PubMed |
| Modification of Seurat v4 for the Development of a Phase Assignment Tool Able to Distinguish between G2 and Mitotic Cells. | Int J Mol Sci | 2024 | 38731808 | PubTator, text mining | PubMed |
| Hub gene identification and immune infiltration analysis in hepatocellular carcinoma: Computational approach. | In Silico Pharmacol | 2024 | 38721057 | PubTator, text mining | PubMed |
| Comprehensive bioinformatics analysis of KIF20A as a prognosis biomarker for clear cell renal cell carcinoma. | Cell Mol Biol (Noisy-le-grand) | 2024 | 38650144 | PubTator, text mining | PubMed |
| CDK1 and CCNA2 play important roles in oral squamous cell carcinoma. | Medicine (Baltimore) | 2024 | 38640322 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10112/papers?page=7